UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15 (d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): January 4,
2008
CONMED
CORPORATION
(Exact
name of registrant as specified in its charter)
|
New
York
|
0-16093
|
16-0977505
|
|
(State
or other jurisdiction of
|
(Commission
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
File
Number)
|
Identification
No.)
|
525
French Road
Utica,
New York 13502
(Address
of principal executive offices, including zip code)
(315)
797-8375
(Registrant's
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligations of the registrant under any of the following
provisions (See General Instruction A.2 below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.02
Departure of Principal Officers; Election of Directors; Appointment of Principal
Officers
On
January 4, 2008, the Company issued a press release announcing the resignation
of Gerald Woodard, President of CONMED Linvatec, to become CEO of SRI
Surgical. A copy of the press release is attached as Exhibit
99. The resignation will be effective January 30, 2008.
|
Section
9
|
Financial
Statements and Exhibits
|
|
Item
9.01
|
Financial
Statements and Exhibits.
|
|
|
(c)
|
Exhibits
|
The
following exhibits are included herewith:
|
Exhibit
No.
|
Description
of Exhibit
|
|
|
99.
|
Press
Release issued by Registrant on January 4,
2008
|
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
CONMED
CORPORATION
|
||
|
(Registrant)
|
||
|
By:
|
Robert D. Shallish, Jr.
|
|
|
Vice
President – Finance and
|
||
|
Chief
Financial Officer
|
||
Date: January
4, 2008
Exhibit
99
 |
NEWS
RELEASE
|
|
|
CONTACT:
|
||
|
CONMED
Corporation
|
||
|
Robert
Shallish
|
||
|
Chief
Financial Officer
|
||
|
315-624-3206
|
||
|
FD
|
||
|
Brian
Ritchie / Theresa Kelleher
|
||
|
212-850-5600
|
||
For
Release: 4:30 PM Eastern – January 4, 2008
CONMED
Announces Resignation of Company’s CONMED Linvatec
Subsidiary
President
Joseph
J. Corasanti, CEO and President of CONMED, to Assume Interim
Leadership
Role at Company’s Orthopedic Unit
Utica,
New York, January 4, 2008 ----- CONMED Corporation (Nasdaq: CNMD) announced
today that Mr. Gerald G. Woodard, President of the Company’s CONMED Linvatec
subsidiary has resigned, effective January 30, 2008, to become CEO of SRI
Surgical, a publicly traded company that provides central processing and supply
chain management services to hospitals and surgery centers. CONMED
has begun a search for his successor. In the interim, Mr. Joseph J.
Corasanti, CEO and President of CONMED, will lead the management team of CONMED
Linvatec, based in Largo, Florida.
“This
is
a wonderful opportunity for Gerald and all of us within the CONMED organization
wish him success in his future endeavors. Over the past seven years,
Gerald has supervised the Company’s orthopedic product offering and developed an
organization built on customer service. We are confident that this
change will have no material affect on our business, and I look forward to
working closely with our orthopedic team while we search for the most
appropriate candidate,” noted Mr. Corasanti.
CONMED
Profile
CONMED
is
a medical technology company with an emphasis on surgical devices and equipment
for minimally invasive procedures and patient monitoring. The
Company’s products serve the clinical areas of sports medicine-arthroscopy,
powered surgical instruments, electrosurgery, cardiac monitoring disposables,
endosurgery and endoscopic technologies. Surgeons and physicians in a
variety of specialties including orthopedics, general surgery, gynecology,
neurosurgery, and gastroenterology use the Company’s medical
devices. Headquartered in Utica, New York, the Company’s 3,200
employees distribute its products worldwide from several manufacturing
locations.
Forward
Looking Information
This
press release contains
forward-looking statements based on certain assumptions and contingencies that
involve risks and uncertainties. The forward-looking statements are
made pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 and relate to the Company’s performance on a going-forward
basis. The forward-looking statements in this press release involve
risks and uncertainties which could cause actual results, performance or trends,
to differ materially from those expressed in the forward-looking statements
herein or in previous disclosures. The Company believes that all
forward-looking statements made by it have a reasonable basis, but there can
be
no assurance that management’s expectations, beliefs or projections as expressed
in the forward-looking statements will actually occur or prove to be
correct.
# # #